» Articles » PMID: 20019344

Pulmonary Alveolar Proteinosis in Workers at an Indium Processing Facility

Overview
Specialty Critical Care
Date 2009 Dec 19
PMID 20019344
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Two cases of pulmonary alveolar proteinosis, including one death, occurred in workers at a facility producing indium-tin oxide (ITO), a compound used in recent years to make flat panel displays. Both workers were exposed to airborne ITO dust and had indium in lung tissue specimens. One worker was tested for autoantibodies to granulocytemacrophage-colonystimulating factor (GM-CSF) and found to have an elevated level. These cases suggest that inhalational exposure to ITO causes pulmonary alveolar proteinosis, which may occur via an autoimmune mechanism.

Citing Articles

Microarray analysis of gene expression in lung tissues of indium-exposed rats: possible roles of S100 proteins in lung diseases.

Hiraku Y, Tanaka A, Yamamoto M, Nakatani M, Kobayashi M, Kimura E Arch Toxicol. 2024; 99(1):245-258.

PMID: 39516272 PMC: 11742277. DOI: 10.1007/s00204-024-03897-x.


Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis.

Lettieri S, Bonella F, Marando V, Franciosi A, Corsico A, Campo I Eur Respir Rev. 2024; 33(173).

PMID: 39142709 PMC: 11322829. DOI: 10.1183/16000617.0064-2024.


Subchronic toxicity study of indium-tin oxide nanoparticles following intratracheal administration into the lungs of rats.

Matsumura N, Tanaka Y, Ogra Y, Koga K, Shiratani M, Nagano K J Occup Health. 2024; 66(1).

PMID: 38626325 PMC: 11131026. DOI: 10.1093/joccuh/uiae019.


Is Associated with Pulmonary Alveolar Proteinosis: A Retrospective Real-World Audit.

Li M, Liu Q, Wang W, Jiang L Biomedicines. 2023; 11(11).

PMID: 38001910 PMC: 10669482. DOI: 10.3390/biomedicines11112909.


A case report of Indium lung with progressive emphysema and fibrosis underwent lung unilateral transplantation 20 years after the end of the exposure.

Inoue C, Ohkouchi S, Chonan T, Amata A, Hirama T, Saito-Koyama R Diagn Pathol. 2023; 18(1):10.

PMID: 36709285 PMC: 9883848. DOI: 10.1186/s13000-023-01303-1.


References
1.
Chonan T, Taguchi O, Omae K . Interstitial pulmonary disorders in indium-processing workers. Eur Respir J. 2006; 29(2):317-24. DOI: 10.1183/09031936.00020306. View

2.
Lison D, Laloy J, Corazzari I, Muller J, Rabolli V, Panin N . Sintered indium-tin-oxide (ITO) particles: a new pneumotoxic entity. Toxicol Sci. 2009; 108(2):472-81. DOI: 10.1093/toxsci/kfp014. View

3.
Hamaguchi T, Omae K, Takebayashi T, Kikuchi Y, Yoshioka N, Nishiwaki Y . Exposure to hardly soluble indium compounds in ITO production and recycling plants is a new risk for interstitial lung damage. Occup Environ Med. 2007; 65(1):51-5. DOI: 10.1136/oem.2006.029124. View

4.
Ray R, Salm R . A fatal case of pulmonary alveolar proteinosis. Thorax. 1962; 17:257-66. PMC: 1018704. DOI: 10.1136/thx.17.3.257. View

5.
Homma T, Ueno T, Sekizawa K, Tanaka A, Hirata M . Interstitial pneumonia developed in a worker dealing with particles containing indium-tin oxide. J Occup Health. 2003; 45(3):137-9. DOI: 10.1539/joh.45.137. View